Modern approaches to the diagnosis and treatment of cardiac sarcoidosis: results of a cohort study

Aim. To analyze clinical and paraclinical data in patients with documented cardiac sarcoidosis, outlining the key points of diagnosis and selection of the optimal treatment.Material and methods. For the period from 2016 to 2021, 63 patients (50,4±14,1 years) were included in the cohort study on nego...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Mairina, D. V. Ryzhkova, L. B. Mitrofanova, A. V. Ryzhkov, P. M. Murtazalieva, O. M. Moiseeva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2023-06-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5301
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689713627103232
author S. V. Mairina
D. V. Ryzhkova
L. B. Mitrofanova
A. V. Ryzhkov
P. M. Murtazalieva
O. M. Moiseeva
author_facet S. V. Mairina
D. V. Ryzhkova
L. B. Mitrofanova
A. V. Ryzhkov
P. M. Murtazalieva
O. M. Moiseeva
author_sort S. V. Mairina
collection DOAJ
description Aim. To analyze clinical and paraclinical data in patients with documented cardiac sarcoidosis, outlining the key points of diagnosis and selection of the optimal treatment.Material and methods. For the period from 2016 to 2021, 63 patients (50,4±14,1 years) were included in the cohort study on negotiability. Based on a standard examination, 15 patients (41±13 years old) were selected, who continued the examination to confirm the diagnosis of cardiac sarcoidosis. Contrast-enhanced cardiac magnetic resonance imaging (MRI) was performed in 10 patients, while endomyocardial biopsy in 7 patients. All patients underwent 18F-fluorodeoxyglucose positron emission tomography (PET).Results. The most common (53%) electrocardiographic abnormality was right bundle branch block. Ventricular arrhythmias and high-grade atrioventricular block were recorded mainly in patients with documented activity. Regional contractility disorders were predominantly detected in patients with cardiac fibrosis. Delayed contrast enhancement according to cardiac MRI was recorded mainly intramurally in the interventricular septum and subepicardial area of left ventricular (LV) lateral wall. When analyzing the PET results, we found the predominant radiopharmaceutical accumulation in the interventricular septum (56%), lateral (44%) and anterior (33%) LV walls. There was no significant improvement in global LV contractility against the background of immunosuppressive therapy, especially in patients with reduced ejection fraction: initially 49,2±10,1% vs 46,9±14,9% during therapy (p=0,658).Conclusion. A certain apprehensive attitude of the doctor and adherence to the algorithm for early diagnosis of cardiac sarcoidosis allows minimizing the risks of fatal cardiovascular events. On the contrary, in the case of late diagnosis, even the use of aggressive immunosuppressive therapy does not lead to an improvement in global myocardial contractility, and fibrosis zones can cause life-threatening bradyarrhythmias and ventricular arrhythmias.
format Article
id doaj-art-3c76bf2eb682473cac7222a7baa30d9b
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2023-06-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-3c76bf2eb682473cac7222a7baa30d9b2025-08-20T03:21:31Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-06-0128510.15829/1560-4071-2023-53013796Modern approaches to the diagnosis and treatment of cardiac sarcoidosis: results of a cohort studyS. V. Mairina0D. V. Ryzhkova1L. B. Mitrofanova2A. V. Ryzhkov3P. M. Murtazalieva4O. M. Moiseeva5Almazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAim. To analyze clinical and paraclinical data in patients with documented cardiac sarcoidosis, outlining the key points of diagnosis and selection of the optimal treatment.Material and methods. For the period from 2016 to 2021, 63 patients (50,4±14,1 years) were included in the cohort study on negotiability. Based on a standard examination, 15 patients (41±13 years old) were selected, who continued the examination to confirm the diagnosis of cardiac sarcoidosis. Contrast-enhanced cardiac magnetic resonance imaging (MRI) was performed in 10 patients, while endomyocardial biopsy in 7 patients. All patients underwent 18F-fluorodeoxyglucose positron emission tomography (PET).Results. The most common (53%) electrocardiographic abnormality was right bundle branch block. Ventricular arrhythmias and high-grade atrioventricular block were recorded mainly in patients with documented activity. Regional contractility disorders were predominantly detected in patients with cardiac fibrosis. Delayed contrast enhancement according to cardiac MRI was recorded mainly intramurally in the interventricular septum and subepicardial area of left ventricular (LV) lateral wall. When analyzing the PET results, we found the predominant radiopharmaceutical accumulation in the interventricular septum (56%), lateral (44%) and anterior (33%) LV walls. There was no significant improvement in global LV contractility against the background of immunosuppressive therapy, especially in patients with reduced ejection fraction: initially 49,2±10,1% vs 46,9±14,9% during therapy (p=0,658).Conclusion. A certain apprehensive attitude of the doctor and adherence to the algorithm for early diagnosis of cardiac sarcoidosis allows minimizing the risks of fatal cardiovascular events. On the contrary, in the case of late diagnosis, even the use of aggressive immunosuppressive therapy does not lead to an improvement in global myocardial contractility, and fibrosis zones can cause life-threatening bradyarrhythmias and ventricular arrhythmias.https://russjcardiol.elpub.ru/jour/article/view/5301cardiac sarcoidosisdiagnostic algorithmstherapy
spellingShingle S. V. Mairina
D. V. Ryzhkova
L. B. Mitrofanova
A. V. Ryzhkov
P. M. Murtazalieva
O. M. Moiseeva
Modern approaches to the diagnosis and treatment of cardiac sarcoidosis: results of a cohort study
Российский кардиологический журнал
cardiac sarcoidosis
diagnostic algorithms
therapy
title Modern approaches to the diagnosis and treatment of cardiac sarcoidosis: results of a cohort study
title_full Modern approaches to the diagnosis and treatment of cardiac sarcoidosis: results of a cohort study
title_fullStr Modern approaches to the diagnosis and treatment of cardiac sarcoidosis: results of a cohort study
title_full_unstemmed Modern approaches to the diagnosis and treatment of cardiac sarcoidosis: results of a cohort study
title_short Modern approaches to the diagnosis and treatment of cardiac sarcoidosis: results of a cohort study
title_sort modern approaches to the diagnosis and treatment of cardiac sarcoidosis results of a cohort study
topic cardiac sarcoidosis
diagnostic algorithms
therapy
url https://russjcardiol.elpub.ru/jour/article/view/5301
work_keys_str_mv AT svmairina modernapproachestothediagnosisandtreatmentofcardiacsarcoidosisresultsofacohortstudy
AT dvryzhkova modernapproachestothediagnosisandtreatmentofcardiacsarcoidosisresultsofacohortstudy
AT lbmitrofanova modernapproachestothediagnosisandtreatmentofcardiacsarcoidosisresultsofacohortstudy
AT avryzhkov modernapproachestothediagnosisandtreatmentofcardiacsarcoidosisresultsofacohortstudy
AT pmmurtazalieva modernapproachestothediagnosisandtreatmentofcardiacsarcoidosisresultsofacohortstudy
AT ommoiseeva modernapproachestothediagnosisandtreatmentofcardiacsarcoidosisresultsofacohortstudy